Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management.
Kadura S, Raghu G.
Eur Respir Rev. 2021 Jun 23;30(160):210011. doi: 10.1183/16000617.0011-2021. Print 2021 Jun 30.
Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease.
Akiyama M, Kaneko Y.
Autoimmun Rev. 2022 May;21(5):103056. doi: 10.1016/j.autrev.2022.103056. Epub 2022 Feb 1.
Etiology and Pathogenesis of Rheumatoid Arthritis-Interstitial Lung Disease.
Kim Y, Yang HI, Kim KS.
Int J Mol Sci. 2023 Sep 25;24(19):14509. doi: 10.3390/ijms241914509.
Identification, Monitoring, and Management of Rheumatoid Arthritis-Associated Interstitial Lung Disease.
Koduri G, Solomon JJ.
Arthritis Rheumatol. 2023 Dec;75(12):2067-2077. doi: 10.1002/art.42640. Epub 2023 Oct 4.
The Lung in Rheumatoid Arthritis: Focus on Interstitial Lung Disease.
Spagnolo P, Lee JS, Sverzellati N, Rossi G, Cottin V.
Arthritis Rheumatol. 2018 Oct;70(10):1544-1554. doi: 10.1002/art.40574. Epub 2018 Sep 4.
Management issues in rheumatoid arthritis-associated interstitial lung disease.
England BR, Hershberger D.
Curr Opin Rheumatol. 2020 May;32(3):255-263. doi: 10.1097/BOR.0000000000000703.
Rheumatoid arthritis-associated interstitial lung disease: an overview of epidemiology, pathogenesis and management.
Dai Y, Wang W, Yu Y, Hu S.
Clin Rheumatol. 2021 Apr;40(4):1211-1220. doi: 10.1007/s10067-020-05320-z. Epub 2020 Aug 13.
Treatment Outcomes for Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Real-World, Multisite Study of the Impact of Immunosuppression on Pulmonary Function Trajectory.
Matson SM, Baqir M, Moua T, Marll M, Kent J, Iannazzo NS, Boente RD, Donatelli JM, Dai J, Diaz FJ, Demoruelle MK, Hamblin MB, Mathai SK, Ryu JH, Pope K, Walker CM, Lee JS.
Chest. 2023 Apr;163(4):861-869. doi: 10.1016/j.chest.2022.11.035. Epub 2022 Dec 5.
Rheumatoid arthritis-associated interstitial lung disease: epidemiology, risk/prognostic factors, and treatment landscape.
Fazeli MS, Khaychuk V, Wittstock K, Han X, Crocket G, Lin M, Hill SL, Ferri L.
Clin Exp Rheumatol. 2021 Sep-Oct;39(5):1108-1118. doi: 10.55563/clinexprheumatol/h9tc57. Epub 2021 Feb 26.
Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis.
Joy GM, Arbiv OA, Wong CK, Lok SD, Adderley NA, Dobosz KM, Johannson KA, Ryerson CJ.
Eur Respir Rev. 2023 Mar 8;32(167):220210. doi: 10.1183/16000617.0210-2022. Print 2023 Mar 31.
